MENU
+Compare
ABT
Stock ticker: NYSE
AS OF
Jul 18, 04:59 PM (EDT)
Price
$123.69
Change
+$3.17 (+2.63%)
Capitalization
194.5B

ABT Abbott Laboratories Forecast, Technical & Fundamental Analysis

Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs... Show more

ABT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ABT with price predictions
Jul 17, 2025

ABT's RSI Oscillator stoops into oversold zone

The RSI Indicator for ABT moved into overbought territory on July 17, 2025. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ABT advanced for three days, in of 313 cases, the price rose further within the following month. The odds of a continued upward trend are .

ABT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 307 cases where ABT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on July 09, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ABT as a result. In of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for ABT turned negative on July 02, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 53 similar instances when the indicator turned negative. In of the 53 cases the stock turned lower in the days that followed. This puts the odds of success at .

ABT moved below its 50-day moving average on July 11, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ABT crossed bearishly below the 50-day moving average on July 15, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ABT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.038) is normal, around the industry mean (24.469). P/E Ratio (34.383) is within average values for comparable stocks, (77.706). Projected Growth (PEG Ratio) (6.149) is also within normal values, averaging (5.667). Dividend Yield (0.019) settles around the average of (0.018) among similar stocks. P/S Ratio (4.888) is also within normal values, averaging (42.883).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ABT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
ABT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ABT is expected to report earnings to rise 6.35% to $1.34 per share on October 15

Abbott Laboratories ABT Stock Earnings Reports
Q3'25
Est.
$1.34
Q2'25
Beat
by $0.01
Q1'25
Beat
by $0.02
Q4'24
Est.
$1.34
Q3'24
Beat
by $0.01
The last earnings report on July 17 showed earnings per share of $1.26, beating the estimate of $1.25. With 5.96M shares outstanding, the current market capitalization sits at 194.50B.
A.I.Advisor
published Dividends

ABT is expected to pay dividends on August 15, 2025

Abbott Laboratories ABT Stock Dividends
A dividend of $0.59 per share will be paid with a record date of August 15, 2025, and an ex-dividend date of July 15, 2025. The last dividend of $0.59 was paid on May 15. Read more...
A.I. Advisor
published General Information

General Information

a manufacturer of health care products

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
100 Abbott Park Road
Phone
+1 224 667-6100
Employees
114000
Web
https://www.abbottinvestor.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
UDOW96.631.66
+1.75%
ProShares UltraPro Dow30
MADE27.700.43
+1.58%
iShares U.S. Manufacturing ETF
GHTA30.490.31
+1.01%
Goose Hollow Tactical Allocation ETF
CLSE23.460.03
+0.13%
Convergence Long/Short Equity ETF
MINT100.410.03
+0.03%
PIMCO Enhanced Short Maturity Active ETF

ABT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ABT has been loosely correlated with SYK. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if ABT jumps, then SYK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABT
1D Price
Change %
ABT100%
-8.52%
SYK - ABT
53%
Loosely correlated
-0.50%
STE - ABT
46%
Loosely correlated
-1.33%
MDT - ABT
46%
Loosely correlated
-0.28%
ALC - ABT
45%
Loosely correlated
+0.05%
DGX - ABT
44%
Loosely correlated
+0.69%
More